Jolie M. Siegel Named Executive Vice President, General Counsel of Odyssey Therapeutics

Jolie M. Siegel was named Executive Vice President, General Counsel of Odyssey Therapeutics on January 21, 2026, according to Business Wire.

NameJolie M. Siegel
RoleExecutive Vice President, General Counsel
CompanyOdyssey Therapeutics
IndustryBiotechnology
LocationBoston, MA
MoveAppointment
DateJanuary 21, 2026
SourceBusiness Wire

Odyssey Therapeutics appointed Jolie M. Siegel as Executive Vice President, General Counsel on January 21, 2026, leading legal, compliance, governance and risk management. She most recently was Chief Legal Officer and Corporate Secretary at C4 Therapeutics, and earlier held legal leadership roles at Neon Therapeutics and Intralinks Holdings. (Source: Business Wire.)

Who is the Executive Vice President, General Counsel of Odyssey Therapeutics?

Jolie M. Siegel took the Executive Vice President, General Counsel role at Odyssey Therapeutics in January 2026, as reported by Business Wire. Legal leadership changes often, so check Odyssey Therapeutics’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.

Other general counsel moves in January 2026

Browse every appointment in the General Counsel Directory.

Source: Business Wire. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.